DrChristopher Forsmark

Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium – UF Health and AdventHealth Combined Clinical Center

The Chronic Pancreatitis Clinical Research Consortium

Diabetes RElated to Acute Pancreatitis and its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON)

Internet-Delivered Pain Self-Management to Reduce Pain and Interference in Chronic Pancreatitis

Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes

Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)

Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC) (Patient Care)

A PHASE 4 STUDY TO ASSESS SYMPTOMS OF EXOCRINE PANCREATIC INSUFFICIENCY IN SUBJECTS WITH CYSTIC FIBROSIS OR CHRONIC PANCREATITIS TREATED WITH CREON (PANCRELIPASE) WITH AN ALTERNATE SOURCE OF ACTIVE PHARMACEUTICAL INGREDIENT

Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)

Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients with EPI due to Chronic Pancreatitis (CP)

Development of a clinical prediction screening tool for exocrine pancreatic insufficiency (EPI) in patients with chronic pancreatitis

Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers

U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS

CTOA

LRRK2-Synuclein Interactions with Gut Inflammation in PD Pathogenesis

Creon® (pancrelipase) therapy for subjects with exocrine pancreatic insufficiency (EPI) due to pancreatic cancer: A double-blind, randomized, parallel design with 2 dose cohorts of pancrelipase in resected pancreatic cancer subjects and an open-label single dose cohort in non-resected pancreatic cancer subjects

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC) NOD Study

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)

A PHASE 1, SINGLE DOSE PK AND SAFETY STUDY WITH NI-03 FOLLOWED BY A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NI-03 COMPARED TO PLACEBO IN SUBJECTS WITH CHRONIC PANCREATITIS

U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS

Pancreatic Research Foundation F013777

Gastroenterology Fund - UFF Fund #004611

Scott Research Endowment - UFF Fund #008830